Regeneron Pharmaceuticals

New cholesterol drugs on the horizon, researchers say

Pharmaceutical companies are in a race to debut strong cholesterol-reducing drugs specifically targeted to those who don't respond to traditional medications, cardiologists and researchers said this week.

FDA approves new macular degeneration treatment

The Food and Drug Administration has approved a new drug for the treatment of the wet form of age-related macular degeneration, called Eylea. Macular degeneration is the leading cause of severe vision loss in the elderly.